A dataset non-small-cell lung cancer trial data from Simon et al. (2011)
first column - censor : censoring status; 0=censored, 1=event.
second column - times : time to event
 Simon GR, Extermann M, Chiappori A, Williams C, Begum M, Haura RKE, Ismail-Khan R, Schell M, Antonia SJ, Bepler G. Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced stage non-small cell lung cancer (NSCLC) who are 70 years of age or older. Cancer 2008; 112:2021–2029.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.